Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001453687-25-000110
Filing Date
2025-10-28
Accepted
2025-10-28 16:03:44
Documents
5
Period of Report
2025-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1761681820.html 3  
1 FORM 3 wk-form3_1761681820.xml 3 1732
2 EX-24 a20251027section16poasey.htm EX-24 5305
3 a20251027section16poasey001.jpg GRAPHIC 248502
4 a20251027section16poasey002.jpg GRAPHIC 64767
5 a20251027section16poasey003.jpg GRAPHIC 38261
  Complete submission text file 0001453687-25-000110.txt   492899
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Issuer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address
Seymour June Ann (Reporting) CIK: 0002093716 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37798 | Film No.: 251424758